-
Something wrong with this record ?
SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
A. Bak, H. Pizova, V. Kozik, K. Vorcakova, J. Kos, J. Treml, K. Odehnalova, M. Oravec, A. Imramovsky, P. Bobal, A. Smolinski, Z. Trávníček, J. Jampilek,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2000
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
31671776
DOI
10.3390/ijms20215385
Knihovny.cz E-resources
- MeSH
- Butyrylcholinesterase MeSH
- Chloroplasts MeSH
- Cholinesterase Inhibitors chemistry pharmacology MeSH
- Photosystem II Protein Complex MeSH
- Inhibitory Concentration 50 MeSH
- Carbamates chemistry pharmacology MeSH
- Silicon chemistry MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Docking Simulation MeSH
- Spinacia oleracea MeSH
- THP-1 Cells drug effects MeSH
- Electron Transport drug effects MeSH
- Binding Sites MeSH
- Cell Survival drug effects MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
A set of 25 novel, silicon-based carbamate derivatives as potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors was synthesized and characterized by their in vitro inhibition profiles and the selectivity indexes (SIs). The prepared compounds were also tested for their inhibition potential on photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. In fact, some of the newly prepared molecules revealed comparable or even better inhibitory activities compared to the marketed drugs (rivastigmine or galanthamine) and commercially applied pesticide Diuron®, respectively. Generally, most compounds exhibited better inhibition potency towards AChE; however, a wider activity span was observed for BChE. Notably, benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(2-hydroxyphenyl)carbamoyl]ethyl]-carbamate (2) and benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(3-hydroxyphenyl)carbamoyl]ethyl]-carbamate (3) were characterized by fairly high selective indexes. Specifically, compound 2 was prescribed with the lowest IC50 value that corresponds quite well with galanthamine inhibition activity, while the inhibitory profiles of molecules 3 and benzyl-N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(4-hydroxyphenyl)carbamoyl]ethyl]carbamate (4) are in line with rivastigmine activity. Moreover, a structure-activity relationship (SAR)-driven similarity evaluation of the physicochemical properties for the carbamates examined appeared to have foreseen the activity cliffs using a similarity-activity landscape index for BChE inhibitory response values. The 'indirect' ligand-based and 'direct' protein-mediated in silico approaches were applied to specify electronic/steric/lipophilic factors that are potentially valid for quantitative (Q)SAR modeling of the carbamate analogues. The stochastic model validation was used to generate an 'average' 3D-QSAR pharmacophore pattern. Finally, the target-oriented molecular docking was employed to (re)arrange the spatial distribution of the ligand property space for BChE and photosystem II (PSII).
Global Change Research Institute CAS Belidla 986 4a 60300 Brno Czech Republic
Institute of Chemistry University of Silesia Szkolna 9 40 007 Katowice Poland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005740
- 003
- CZ-PrNML
- 005
- 20200518132044.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20215385 $2 doi
- 035 __
- $a (PubMed)31671776
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bak, Andrzej $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. andrzej.bak@us.edu.pl.
- 245 10
- $a SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors / $c A. Bak, H. Pizova, V. Kozik, K. Vorcakova, J. Kos, J. Treml, K. Odehnalova, M. Oravec, A. Imramovsky, P. Bobal, A. Smolinski, Z. Trávníček, J. Jampilek,
- 520 9_
- $a A set of 25 novel, silicon-based carbamate derivatives as potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors was synthesized and characterized by their in vitro inhibition profiles and the selectivity indexes (SIs). The prepared compounds were also tested for their inhibition potential on photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. In fact, some of the newly prepared molecules revealed comparable or even better inhibitory activities compared to the marketed drugs (rivastigmine or galanthamine) and commercially applied pesticide Diuron®, respectively. Generally, most compounds exhibited better inhibition potency towards AChE; however, a wider activity span was observed for BChE. Notably, benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(2-hydroxyphenyl)carbamoyl]ethyl]-carbamate (2) and benzyl N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(3-hydroxyphenyl)carbamoyl]ethyl]-carbamate (3) were characterized by fairly high selective indexes. Specifically, compound 2 was prescribed with the lowest IC50 value that corresponds quite well with galanthamine inhibition activity, while the inhibitory profiles of molecules 3 and benzyl-N-[(1S)-2-[(tert-butyldimethylsilyl)oxy]-1-[(4-hydroxyphenyl)carbamoyl]ethyl]carbamate (4) are in line with rivastigmine activity. Moreover, a structure-activity relationship (SAR)-driven similarity evaluation of the physicochemical properties for the carbamates examined appeared to have foreseen the activity cliffs using a similarity-activity landscape index for BChE inhibitory response values. The 'indirect' ligand-based and 'direct' protein-mediated in silico approaches were applied to specify electronic/steric/lipophilic factors that are potentially valid for quantitative (Q)SAR modeling of the carbamate analogues. The stochastic model validation was used to generate an 'average' 3D-QSAR pharmacophore pattern. Finally, the target-oriented molecular docking was employed to (re)arrange the spatial distribution of the ligand property space for BChE and photosystem II (PSII).
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a butyrylcholinesterasa $7 D002091
- 650 _2
- $a karbamáty $x chemie $x farmakologie $7 D002219
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a chloroplasty $7 D002736
- 650 _2
- $a cholinesterasové inhibitory $x chemie $x farmakologie $7 D002800
- 650 _2
- $a transport elektronů $x účinky léků $7 D004579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a fotosystém II - proteinový komplex $7 D045332
- 650 _2
- $a křemík $x chemie $7 D012825
- 650 _2
- $a Spinacia oleracea $7 D018724
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a THP-1 buňky $x účinky léků $7 D000074084
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pizova, Hana $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 612 42 Brno, Czech Republic. pizovah@gmail.com.
- 700 1_
- $a Kozik, Violetta $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. violetta.kozik@us.edu.pl.
- 700 1_
- $a Vorcakova, Katarina $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. katarina.vorcakova@upce.cz.
- 700 1_
- $a Kos, Jiri $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic, jiri.kos@upol.cz (J.K.). jiri.kos@upol.cz.
- 700 1_
- $a Treml, Jakub $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 612 42 Brno, Czech Republic. tremlj@vfu.cz.
- 700 1_
- $a Odehnalova, Klara $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 612 42 Brno, Czech Republic. odehnalovak@vfu.cz.
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic. oravec.m@czechglobe.cz.
- 700 1_
- $a Imramovsky, Ales $u Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. ales.imramovsky@upce.cz.
- 700 1_
- $a Bobal, Pavel $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 612 42 Brno, Czech Republic. pavelbobal@yahoo.com.
- 700 1_
- $a Smolinski, Adam $u Department of Energy Saving and Air Protection, Central Mining Institute, Plac Gwarkow 1, 40 166 Katowice, Poland. smolin@gig.katowice.pl.
- 700 1_
- $a Trávníček, Zdeněk $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic, jiri.kos@upol.cz (J.K.). zdenek.travnicek@upol.cz.
- 700 1_
- $a Jampilek, Josef $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic, jiri.kos@upol.cz (J.K.). josef.jampilek@gmail.com.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 21 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31671776 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132044 $b ABA008
- 999 __
- $a ok $b bmc $g 1524598 $s 1095796
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 21 $e 20191029 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20200511